• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-148a 抑制通过雌激素受体 α 抑制 PI3K/AKT 信号通路对去卵巢诱导的骨质疏松症发挥保护作用。

MicroRNA‑148a inhibition protects against ovariectomy‑induced osteoporosis through PI3K/AKT signaling by estrogen receptor α.

机构信息

Department of Joint Surgery, Tianjin Hospital, Tianjin 300211, P.R. China.

出版信息

Mol Med Rep. 2018 Jun;17(6):7789-7796. doi: 10.3892/mmr.2018.8845. Epub 2018 Apr 5.

DOI:10.3892/mmr.2018.8845
PMID:29620276
Abstract

The present study aimed to investigate the effect of microRNA‑148a downregulation on osteoporosis by using an ovariectomized rat model. Reverse transcription‑quantitative polymerase chain reaction was used to analyze microRNA‑148a expression levels, MTT and flow cytometry assays were used to examine cytotoxicity and apoptosis, respectively. The gap‑associated proteins were quantified using western blotting. The expression of microRNA‑148a was significantly increased in osteoporosis rat following ovariectomy. Overexpression of microRNA‑148a significantly promoted apoptosis and inhibited cell growth, whereas downregulation of microRNA‑148a significantly reduced apoptosis and increased cell growth. Overexpression of microRNA‑148a significantly reduced estrogen receptor a (ERα) protein expression and suppressed phosphoinositide‑3‑kinase regulatory subunit 1 (PI3K) and phosphorylated‑protein kinase B (AKT) protein expression in osteoblasts in vitro. The inhibition of ERα increased the microRNA‑148a effect on apoptosis in osteoblasts in vitro. Subsequently, LY294002, an PI3K inhibitor, significantly increased the effect of microRNA‑148a on apoptosis in osteoblasts in vitro. The findings of the present study revealed that anti‑microRNA‑148a protected cells against ovariectomy‑induced osteoporosis through ERα by PI3K/AKT signaling.

摘要

本研究旨在通过建立去卵巢大鼠模型来研究下调 microRNA-148a 对骨质疏松症的影响。采用反转录-定量聚合酶链反应(RT-qPCR)分析 microRNA-148a 表达水平,采用 MTT 法和流式细胞术分别检测细胞毒性和细胞凋亡。采用蛋白质印迹法检测缝隙连接蛋白。结果显示,去卵巢大鼠骨质疏松症时 microRNA-148a 表达显著增加。过表达 microRNA-148a 可显著促进细胞凋亡并抑制细胞生长,而下调 microRNA-148a 则可显著减少细胞凋亡并促进细胞生长。过表达 microRNA-148a 可显著降低体外成骨细胞中雌激素受体 α(ERα)蛋白表达,并抑制磷酸肌醇 3-激酶(PI3K)调节亚基 1(PI3K)和磷酸化蛋白激酶 B(AKT)蛋白表达。抑制 ERα 可增加 microRNA-148a 对体外成骨细胞凋亡的影响。随后,PI3K 抑制剂 LY294002 可显著增加 microRNA-148a 对体外成骨细胞凋亡的影响。本研究结果表明,抗 microRNA-148a 通过 PI3K/AKT 信号通路通过 ERα 保护细胞免受去卵巢诱导的骨质疏松症。

相似文献

1
MicroRNA‑148a inhibition protects against ovariectomy‑induced osteoporosis through PI3K/AKT signaling by estrogen receptor α.miR-148a 抑制通过雌激素受体 α 抑制 PI3K/AKT 信号通路对去卵巢诱导的骨质疏松症发挥保护作用。
Mol Med Rep. 2018 Jun;17(6):7789-7796. doi: 10.3892/mmr.2018.8845. Epub 2018 Apr 5.
2
The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis.PI3K/AKT细胞信号通路参与骨质疏松症的调控。
J Recept Signal Transduct Res. 2015;35(6):640-5. doi: 10.3109/10799893.2015.1041647. Epub 2015 Sep 22.
3
PSMC6 promotes osteoblast apoptosis through inhibiting PI3K/AKT signaling pathway activation in ovariectomy-induced osteoporosis mouse model.PSMC6 通过抑制卵巢切除诱导骨质疏松症小鼠模型中 PI3K/AKT 信号通路的激活促进成骨细胞凋亡。
J Cell Physiol. 2020 Jul;235(7-8):5511-5524. doi: 10.1002/jcp.29261. Epub 2020 Feb 4.
4
MiR-320a was highly expressed in postmenopausal osteoporosis and acts as a negative regulator in MC3T3E1 cells by reducing MAP9 and inhibiting PI3K/AKT signaling pathway.miR-320a 在绝经后骨质疏松症中高表达,通过降低 MAP9 抑制 PI3K/AKT 信号通路在 MC3T3E1 细胞中起负调控作用。
Exp Mol Pathol. 2019 Oct;110:104282. doi: 10.1016/j.yexmp.2019.104282. Epub 2019 Jul 10.
5
Effect of lncRNA AK023948 on rats with postmenopausal osteoporosis via PI3K/AKT signaling pathway.lncRNA AK023948 通过 PI3K/AKT 信号通路对去卵巢骨质疏松大鼠的影响。
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2181-2188. doi: 10.26355/eurrev_202003_20483.
6
QingYan formula extracts protect against postmenopausal osteoporosis in ovariectomized rat model via active ER-dependent MEK/ERK and PI3K/Akt signal pathways.清咽方提取物通过激活 ER 依赖性 MEK/ERK 和 PI3K/Akt 信号通路防治去卵巢大鼠骨质疏松症。
J Ethnopharmacol. 2021 Mar 25;268:113644. doi: 10.1016/j.jep.2020.113644. Epub 2020 Nov 29.
7
Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized Rats.绿原酸通过Shp2/PI3K/Akt信号通路预防去卵巢大鼠骨质疏松症。
PLoS One. 2016 Dec 29;11(12):e0166751. doi: 10.1371/journal.pone.0166751. eCollection 2016.
8
Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.盐酸益母草碱通过抑制NF-κB和PI3K/Akt信号通路来抑制破骨细胞生成,并预防与雌激素缺乏相关的骨质疏松症。
Bone. 2015 Jun;75:128-37. doi: 10.1016/j.bone.2015.02.017. Epub 2015 Feb 21.
9
Anti-microRNA-132 causes sevoflurane‑induced neuronal apoptosis via the PI3K/AKT/FOXO3a pathway.抗 microRNA-132 通过 PI3K/AKT/FOXO3a 通路引起七氟醚诱导的神经元凋亡。
Int J Mol Med. 2018 Dec;42(6):3238-3246. doi: 10.3892/ijmm.2018.3895. Epub 2018 Sep 25.
10
Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.通过Polo样激酶1经PI3K/Akt途径调控胰腺癌中的细胞凋亡和增殖
Oncol Rep. 2016 Jul;36(1):49-56. doi: 10.3892/or.2016.4820. Epub 2016 May 18.

引用本文的文献

1
Citrate: a key signalling molecule and therapeutic target for bone remodeling disorder.柠檬酸盐:骨重塑紊乱的关键信号分子和治疗靶点。
Front Endocrinol (Lausanne). 2025 Jan 16;15:1512398. doi: 10.3389/fendo.2024.1512398. eCollection 2024.
2
Insights and implications of sexual dimorphism in osteoporosis.骨质疏松症中性别二态性的见解与意义。
Bone Res. 2024 Feb 18;12(1):8. doi: 10.1038/s41413-023-00306-4.
3
ERK-estrogen receptor α signaling plays a role in the process of bone marrow mesenchymal stem cell-derived exosomes protecting against ovariectomy-induced bone loss.
ERK-雌激素受体 α 信号通路在骨髓间充质干细胞来源的外泌体防止去卵巢诱导的骨丢失的过程中发挥作用。
J Orthop Surg Res. 2023 Mar 27;18(1):250. doi: 10.1186/s13018-023-03660-5.
4
Recent advancements of miRNAs in the treatment of bone diseases and their delivery potential.微小RNA在骨疾病治疗中的最新进展及其递送潜力。
Curr Res Pharmacol Drug Discov. 2022 Dec 27;4:100150. doi: 10.1016/j.crphar.2022.100150. eCollection 2023.
5
Osteoporosis pathogenesis and treatment: existing and emerging avenues.骨质疏松症的发病机制和治疗:现有和新兴途径。
Cell Mol Biol Lett. 2022 Sep 4;27(1):72. doi: 10.1186/s11658-022-00371-3.
6
The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential.微小 RNA 在骨骼疾病中的新兴作用及其治疗潜力。
Molecules. 2021 Dec 30;27(1):211. doi: 10.3390/molecules27010211.
7
Up-regulation of SIRT1 induced by 17beta-estradiol promotes autophagy and inhibits apoptosis in osteoblasts.17β-雌二醇诱导的 SIRT1 上调促进成骨细胞自噬并抑制细胞凋亡。
Aging (Albany NY). 2021 Oct 28;13(20):23652-23671. doi: 10.18632/aging.203639.
8
Baicalein ameliorates osteoporosis via AKT/FOXO1 signaling.黄芩素通过AKT/FOXO1信号通路改善骨质疏松症。
Aging (Albany NY). 2021 Jul 1;13(13):17370-17379. doi: 10.18632/aging.203227.
9
Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis.毛蕊花糖苷促进脂肪间充质干细胞成骨分化以预防去卵巢诱导的骨质疏松症。
J Orthop Surg Res. 2021 Apr 26;16(1):279. doi: 10.1186/s13018-021-02389-3.
10
The miRNA-15b/USP7/KDM6B axis engages in the initiation of osteoporosis by modulating osteoblast differentiation and autophagy.miRNA-15b/USP7/KDM6B 轴通过调节成骨细胞分化和自噬参与骨质疏松症的发生。
J Cell Mol Med. 2021 Feb;25(4):2069-2081. doi: 10.1111/jcmm.16139. Epub 2021 Jan 12.